Related Experiment Videos
Clinical results with exposed polyglactin 910 resorbable membranes for guided tissue regeneration
G Urbani1, A Graziani, G Lombardo
1Department of Periodontics, University of Verona, Policlinico Borgo Roma, Italy.
Abstract:
Three cases are presented where early exposure of a resorbable membrane occurred during guided tissue regeneration therapy. An antimicrobial regimen was selected to determine whether infection of exposed membranes could be controlled to the point of achieving acceptable clinical results without membrane removal. The results suggest that with the use of the antimicrobial regimen: (1) exposure is compatible with successful clinical results, and (2) removal is not necessary.
Insights
Early resorbable membrane exposure during guided tissue regeneration can be managed with antimicrobials. This approach allows successful clinical outcomes without the need for membrane removal, simplifying the procedure.
Area of Science:
- Periodontology
- Regenerative Medicine
- Biomaterials
Background:
- Guided tissue regeneration (GTR) utilizes barrier membranes to exclude soft tissues, promoting periodontal regeneration.
- Early membrane exposure is a known complication that can lead to infection and compromise GTR outcomes.
- Resorbable membranes offer advantages by eliminating the need for a second surgical procedure for removal.
Observation:
- Three clinical cases are presented involving early exposure of resorbable membranes during GTR therapy.
- An antimicrobial regimen was implemented to manage potential infections associated with exposed membranes.
- The primary objective was to assess if infection could be controlled without surgical intervention.
Findings:
- The selected antimicrobial regimen effectively controlled infection in exposed resorbable membranes.
- Successful clinical results were achieved despite the early membrane exposure.
- Membrane removal was not required to obtain favorable treatment outcomes.
Implications:
- Early resorbable membrane exposure in GTR may not necessitate removal when managed with appropriate antimicrobial therapy.
- This finding could lead to modified clinical protocols, potentially reducing treatment complexity and patient morbidity.
- Further research is warranted to validate these findings across a larger patient cohort and diverse clinical scenarios.